QualityStocks
  The QualityStocks Daily Newsletter for Monday December 14th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

OTC Picks (AMSZ)

2.

Monster Stocks (BGEM)

3.

Top Best Penny Stocks (WCRS)


The QualityStocks Daily

Blue Gem Enterprise (BGEM)

Today, Monster Stox, Free Investment Report, The Dean, Stock Spice, The Ox of Wallstreet, Stock Marketing Inc., Crazy Penny Stocks, Titan Stocks, and Stock Picks reported on Blue Gem Enterprise (BGEM), and we highlight the Company as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Blue Gem Enterprise is an emerging beverage distribution company. They are a full service direct store beverage-distribution company. The Company's mission is to become one of the leading distributors of non-alcoholic beverages and foods in the state of Florida. Blue Gem Enterprise has their corporate headquarters in Miami, Florida.

Blue Gem Enterprise serves the area from Southern Georgia through the Florida Keys. This includes major chains, independent stores, hospitals, gyms, hotels, and other retailers. The Company distributes various non-alcohol beverages, including ice teas, juices, waters, shots, and carbonated soft drinks. They expect to manage and distribute select allied brands with beverage manufacturers.

Last month, Blue Gem Enterprise reported that they hired veteran beverage-industry executive Bob Friedopfer to head up the Company's sales and expansion plan. Mr. Friedopfer will implement a growth strategy, adding new products to distribute throughout South Florida independent and larger chain stores.

On December 12, 2009, Blue Gem Enterprise announced that professional football player Terrell Owens signed an exclusive endorsement deal for Title Sports Drink. This is a new all natural electrolyte replenishment drink manufactured by The Electric Beverage Company and distributed exclusively by Blue Gem Enterprise. The deal includes TV commercials, public appearances, and product placement featuring the all pro wide receiver and reality television personality known as T.O.

Today, Blue Gem Enterprise announced that they have now expanded their product offerings to include Hawaiian Punch, Canada Dry Ginger Ale, Orange Crush, and Yoo Hoo, among others. Blue Gem has been focusing on distributing Title Sports Drink. After establishing independent routes throughout South Florida, the Company has made the transition to become a distributor for a broad spectrum of national brands .The distribution of these new brands will begin January 1, 2010.

We're tracking Blue Gem Enterprise (BGEM) on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Blue Gem Enterprise (BGEM) closed Monday's trading session at $0.6490 up 85.96 percent. Volume was 13,331,306.

NetSol Technologies Inc. (NTWK)

Last week Greenbackers reported on NetSol Technologies Inc. (NTWK), OTC Journal, Momentum Traders, Cool Penny Stocks, Stock Rich, HotOTC.com, OTC Picks did earlier, and we highlight the Company as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Founded in 1995, NetSol Technologies Inc. is a worldwide provider of global business services and enterprise application solutions. The company uses their BestShoring™ practices and experienced resources in analysis, development, quality assurance, and implementation to deliver high quality, cost-effective solutions. Trading on the NASDAQ Capital Market, NetSol Technologies Inc. has their headquarters in Calabasas, California.

The company’s clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies. Along with their corporate headquarters, NetSol Technologies has operations and offices in Adelaide, Bangkok, Beijing, Lahore, London, and San Pedro Sula.

The company’s product and services offerings, specialized by industry, include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, and custom development. They also include systems integration and technical services for the global financial, healthcare, insurance, energy, and technology markets.

Last week, NetSol announced that they started the process to form a wholly owned subsidiary in China. NetSol has been operating from their representative office in Beijing. NetSol plans to offer additional services into the local market, through a new Chinese Delivery Center, in addition to their core NetSol Financial Suite™ solutions.

On December 9, 2009, NetSol Technologies, Inc. announced that the Company received a major software and IT services contract with a new joint venture auto finance company based in China. NetSol will provide full life cycle processing for the customers' auto finance business through the NetSol Financial Suite™ (NFS). Their NFS solution provides asset finance companies a state-of-the-art tool to manage business process, workflow framework, and complete portfolio management and processing. The value of the contract is more than $2 million over the life of the agreement, including customization, implementation, maintenance and support.

We're keeping our eye on NetSol Technologies Inc. (NTWK), and we're tracking them on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

NetSol Technologies Inc. (NTWK) closed Monday's session at $0.82 down 3.53 percent. Volume was 117,027.

Cityside Tickets (CIST)

Today we choose to highlight Cityside Tickets (CIST) as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Cityside Tickets is a company that offers a diverse range of tickets for sale through their website at www.citysidetickets.com. In addition, visitors to the company’s website can also choose to use the site to sell tickets they have available. Trading on the Pink Sheets, Cityside Tickets has their headquarters in Boston, Massachusetts.

The Company offers Concert Tickets, Theatre Tickets, and Sports Tickets to their customers. Currently, Cityside Tickets is offering concert tickets for acts such as Taylor Swift, Bon Jovi, Lady Gaga, and Elton John & Billy Joel, to name a few. For Theatre tickets, the Company is currently offering tickets for Wicked, The Jersey Boys, South Pacific, and Phantom of the Opera, among others. Their focus is on offering tickets to quality theatre acts in a variety of cities.

Cityside Tickets also offers tickets to Major League Baseball, NBA Basketball, NFL Football, and NHL Hockey events. They also offer Monster Jam tickets as well as National Finals Rodeo Tickets. In addition, the Company offers Ultimate Fighting Championship tickets, U.S. Open Tennis Championship tickets, and WWE-World Wrestling Entertainment tickets.

Cityside Tickets also offers tickets to NASCAR racing events. This includes tickets to the Daytona 500 at Daytona International Speedway as well as the Atlanta Motor Speedway, Darlington Raceway, Indianapolis Motor Speedway, Michigan International Speedway, Pocono Raceway, and Watkins Glen International. This is in addition to a host of other racetrack offerings Cityside Tickets presents on their web portal.

For this holiday season, the Company is offering tickets for the Radio City Music Hall Christmas Spectacular. This show features the famous Rockettes. Cityside Ticket website visitors can utilize the city search mechanism on the Company's site to fine-tune their ticket searches.

The Company also has a user-friendly page for website visitors to offer their tickets for sale. A website visitor fills out a form with their contact information. They also include the name of the event their selling, as well as the date, time, and where the event is playing. In addition, the visitor also gives the Section, Row, and Seat number of a ticket. They must also input the asking price per ticket they are offering for sale on the Cityside Ticket site.

We have Cityside Tickets (CIST) locked on our radar screens as "One to Watch" this week, here at the QualityStocks Daily Newsletter.

Cityside Tickets (CIST) closed Monday's trading session at $0.01 on no volume.

ProtoSource Corp. (PSCO)

Today we highlight ProtoSource Corp. (PSCO), here at the QualityStocks Daily Newsletter.

Founded in 1988, ProtoSource Corp.'s long-term business strategy is to focus on the delivery of technologically sophisticated, database-driven, business-to-business services and solutions. Headquartered in Bethlehem, Pennsylvania, the Company merged with P2i at the start of 2004. They trade on the OTCBB as part of the Business Software & Services industry in the Technology sector. ProtoSource Corp. serves retailers, newspapers, and magazine publishers in North America and Europe.

The Company's main business is the mining, management and databasing of print content for the Newspaper industry. They then deliver this back to clients in a broad spectrum of formats to fit their ever-changing needs. They do this via ProtoSource's business unit, P2i Newspapers.

ProtoSource Corp. launched a business unit called P2i Solutions in 2004. P2i Solutions works to grow sales in verticals including Commercial Printing, Government, Legal, and Financial Services. However, ProtoSource Corp.'s P2i Newspapers focuses almost exclusively on services for Newspaper Publishers.

P2i Newspapers provides revenue generating digital opportunities through their own suite of products. They also provide these opportunities by powering database-powered services and solutions for the publishing and advertising industry.

The core business at P2i is the rapid extraction, conversion, hosting, and serving of digital content to their customers. Often, that digital content is repurposed from files originally created and used for print products. The content is delivered directly to the web sites of their clients in a format they require.  P2i has company facilities in Hellertown, Pennsylvania; Kuala Lumpur, Malaysia and Fresno, California delivering data to over 1,200 publications, directly or through business partners.

ProtoSource Corp. also provides bilingual technical support services, Web-hosting, and Internet connectivity. The Company's BX Solutions is an Internet Service Provider (ISP) located in Fresno, California, with more than 12,000 POPs throughout the United States.  BX Solutions focuses on providing technical support services, either independently or as part of the full-service ISP service.

ProtoSource Corp. (PSCO) closed Monday's session at $0.0250 down 28.57 percent. Volume was 87,000.

Immunovaccine Inc. (IMV.V)

Today we are highlighting Immunovaccine Inc. (IMV.V), here at the QualityStocks Daily Newsletter.

Immunovaccine Inc. is a biotechnology company that focuses on the commercialization of their novel vaccine technology and product candidates. Trading on the TSX Venture Exchange, the Company continues to strengthen their vaccine pipeline through licensing and strategic partnerships. This is to develop therapeutic cancer and infectious disease vaccines. Immunovaccine Inc. has their corporate headquarters in Halifax, Nova Scotia, Canada.

The Company's patented vaccine delivery and enhancement technology is the DepoVax™ platform. It has achieved positive pre-clinical safety data.   Their technology has attracted multiple partnerships and generated revenues through two licenses of their technology to Pfizer Animal Health. The Company's DPX-0907 is a therapeutic vaccine against ovarian, breast, and prostate cancer that, in conjunction with their vaccine delivery technology, is set to enter Phase 1 human clinical trials. 

Immunovaccine Inc.'s DepoVax™ technology is an improvement on their original discovery that a surprising formulation of immunogens in liposomes and then in oil carrier results in significantly enhanced immune responses.  DepoVax™ is a dry product and is inherently stable.  Once prepared for injection, the active components stay in the oil phase. This creates a long lasting 'depot effect' that elicits a potent humoral and/or cellular immunity. This is even with a single dose.

Immunovaccine Inc. will pursue a fast-track regulatory strategy by taking the product through a short Phase 1 into a Phase 2 clinical trial.  The Company is also conducting proof of concept and pre-clinical studies for infectious disease vaccines: Pseudomonas aeruginosa, single dose pandemic influenza, and Hepatitis B. 

The Company continues to strengthen their vaccine pipeline via licensing and strategic collaborating. They have positive pre-clinical safety data and recent partnerships with LIAI, NIH, Yokohoma City University, Defense Research & Development Canada, FIT Biotech, and Immunotope Inc.

On November 10, 2009, Immunovaccine Inc. signed a collaborative agreement with the National Cancer Institute (NCI) in Maryland, USA. The research collaboration involves formulating NCI's cancer vaccine antigens in DepoVax™, Immunovaccine's vaccine enhancement system. The research team at Immunovaccine will be collaborating with NCI investigator Dr. Jeffrey Schlom, head of the Immunotherapeutics group and chief of the Laboratory of Tumor Immunology & Biology.

Last Wednesday, Immunovaccine Inc. announced that their Investigational New Drug (IND) application for their therapeutic cancer vaccine, DPX-0907, received clearance by the U.S. Food and Drug Administration (FDA). DPX-0907 is the Company's lead therapeutic vaccine candidate.

The Phase 1 clinical trial for DPX-0907 will conduct at five sites in the United States. It is on track to begin enrolling patients with breast, ovarian, and prostate cancers by the end of Quarter 1 2010. The Phase 1 clinical trial will evaluate the safety and tolerability of Immunovaccine Inc.'s patented DepoVax™ delivery system and seven tumor-associated antigens.

Immunovaccine Inc. (IMV.V) closed Monday's trading session at $1.50 up 2.74 percent. Volume was 58,394.

Novelos Therapeutics, Inc. (NVLT)

SmallCap Voice, Cool Penny Stocks, and HotOTC.com reported on Novelos Therapeutics, Inc. (NVLT), and we highlight the Company, here at the QualityStocks Daily Newsletter.

Novelos Therapeutics, Inc. is a biopharmaceutical company commercializing oxidized glutathione-based compounds for the treatment of cancer and hepatitis. Oxidized glutathione is a natural metabolite that is part of the glutathione pathway. This pathway is the primary determinant of intracellular redox (oxidation/reduction) potential. Its role in cell detoxification is well studied and understood. It has recognition as an important physiological regulator of redox-sensitive cell signaling pathways in multiple cell types. Novelos Therapeutics, Inc. trades on the OTCBB and they have their headquarters in Newton, Massachusetts.

The Company's lead products are believed to act, in part, through modification of cellular redox status. This leads to post-translational modification (glutathionylation) of critical regulatory proteins that mediate disease-relevant processes. These include tumor invasiveness, immune function, and blood cell formation.

NOV-002, the lead compound currently in Phase 3 development for lung cancer under a Special Protocol Assessment (SPA) and Fast Track, acts together with chemotherapy as a chemopotentiator and a chemoprotectant. This is by regulating redox-sensitive cell signaling pathways. NOV-002 is also in Phase 2 development for early-stage breast cancer and chemotherapy-resistant ovarian cancer. Novelos has a partnership with Mundipharma to develop and commercialize NOV-002 in Europe and Asia (excluding China).

Novelos has a second compound called NOV-205. It acts as a hepatoprotective agent with immunomodulating and anti-inflammatory properties. NOV-205 is in Phase 1b development for chronic hepatitis C non-responders. Both compounds have a partnership with Lee's Pharm in China.

Novelos Therapeutics, Inc.'s intellectual property includes six U.S., two European, and one Japanese issued patents. Novelos has filed more than 30 patent applications worldwide, with coverage including composition of matter, method of use, and manufacturing.

Last month, Novelos Therapeutics, Inc. reported that Novelos issued and sold to Purdue Pharma L.P., an existing investor, 8,333,334 shares of Novelos' common stock and warrants, expiring on December 31, 2015, to purchase 2,916,668 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $5.5 million. The sale represented the subsequent and final closing under a securities purchase agreement dated August 25, 2009 between the parties.

"I am very pleased with Purdue's continued support, providing Novelos funds for a robust development program into 3Q 2010," said Harry Palmin, President and CEO of Novelos.

Novelos Therapeutics, Inc. (NVLT) closed Monday's trading session at $1.18 up 12.38 percent. Volume was 3,042,157.

Western Capital Resources, Inc. (WCRS)

Last week, Simply Best Penny Stocks reported on Western Capital Resources, Inc. (WCRS), Stock Guru did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Western Capital Resources, Inc. presently operates approximately 55 cash advance or "payday" lending stores. They operate these in Nebraska, Iowa, North Dakota, South Dakota, Wyoming, Montana, Kansas, Colorado, Wisconsin, and Utah. Western Capital Resources, Inc. trades on the OTC Bulletin Board and they have their headquarters in Omaha, Nebraska.

The Company provides customers with short-term cash advance loans. These normally range from $100 to $500. They also provide their customers ancillary consumer financial products and services that are complementary to the cash advance lending business. These include check-cashing services, money transfers, and money orders.

Western Capital Resources, Inc. also has a growing Cricket Wireless business. This side of their business involves the sale of Cricket Wireless phones and accessories. Cricket phones are prepaid cellular phones that function for a period, without usage limitations, for a flat fee. The Company currently operates approximately 35 Cricket wireless retail stores. They operate these stores in Illinois, Indiana, Kansas, Missouri, Maryland, Nebraska, and Texas.

Last month, Western Capital Resources, Inc. reported increased quarterly revenue of 40 percent year-over-year according to the Company's third quarter 10-Q filing. Total revenues for Quarter 3 2009 were $4.57 million compared to $3.23 million last year. The increase in revenue was primarily attributable to the expansion of Cricket wireless stores over the past 12 months. EBITDA for the third quarter was $654,278 compared to $577,316 for the prior period in 2008. Net income was $198,000 before dividends.

John Quandahl, Chief Executive Officer said last month, "We are continuing to make very positive strides each quarter by decreasing expenses associated with the rapid expansion of the number of Cricket stores. We believe revenue growth will be fueled by both the maturation of new stores opened in the past 12 months and continued acquisitions."

Today, Western Capital Resources, Inc. (WCRS) closed trading at $0.55 up 83.33 percent. Volume was 608,725.

Alloy Steel International Inc. (AYSI)

OTC Picks reported earlier on Alloy Steel International Inc. (AYSI), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on NASDAQ's OTC Bulletin Board, Alloy Steel International, Inc. engages in the manufacture and distribution of Arcoplate, a wear-resistant alloy overlay wear plate. The Company offers fused-alloy steel plates for installation and use in structures and machinery that suffer wear. Alloy Steel International Inc. has their corporate headquarters in Malaga Perth Australia.

The Company works to develop leading edge technology in Engineering and Wear Resistant Materials. One thing their Arcoplate does is help enterprises reduce Hangup. Hangup is a problem experienced where material binds to part or all of a section of the fixed plant (or mobile plant), limiting the flow of material as the build up increases. In severe situations, section or sections of a plant need closing down for extended periods to remove the restrictions caused by the hangup.

Arcoplate is a solution for hangup and is typically supplied in the mill finish, as it is a smooth thermo-clad plate. After a period of time the mill finish will be worn back, to reveal a smooth "mirror" finish. For extreme hang up applications, Arcoplate can be polished prior to delivery. Arcoplate assists in minimizing hang up through a dense, refined metallurgical structure giving an extremely low coefficient of friction. It has resistance to indentation and its microstructure limits the extent of erosive attack.

In August of this year, the Company's new Arcoplate manufacturing plant, specifically designed to produce extra thick super alloy wear plate, was successfully commissioned and commenced production. The new production mill is for continuous cast fused alloy cladding. It is the only process capable of producing a bi-metallic fused super alloy wear plate in a single pass in a thickness over 20mm (just over 3/4 of an inch) in a single contentious casting operation.  

Alloy Steel Australia (Int) Pty Ltd. signed a long-term strategic supply agreement this year with BHP Billiton to supply Arcoplate Wear Resistant Super Alloy Wearplate for iron ore mining operations in Western Australia. The initial product is for the multi-million dollar expansion of their operations in the Pilbara area of Western Australia. Alloy Steel Australia (Int) Pty Ltd. is a wholly owned subsidiary of Alloy Steel International Inc.

Today, Alloy Steel International Inc. (AYSI) closed at $2.25 down 0.88 percent. Volume was 13,745.

The QualityStocks Company Corner

Muscle Flex Inc. (MFLI)

The QualityStocks Daily Newsletter would like to spotlight Muscle Flex Inc. (MFLI). Today, Muscle Flex Inc. closed trading at $0.0140. Their volume today was 1,119,371 shares.

Muscle Flex Inc. (MFLI) announced preliminary results from their initial week of national test advertising for the Beagle StepFit. Muscle Flex is very pleased with a number of metrics associated with first week of advertising that aired on 7 national cable stations Last week.

Muscle Flex Inc. (MFLI) is a leading edge fitness, health and lifestyle company focused on developing exciting brands and new products to market using direct response TV advertising and infomercials as well as cutting edge brand and image marketing. The company has designed all its products with the average person's lifestyle in mind.

Muscle Flex Inc. VATA Brasil sports and active wear collection is an ultra comfortable active wear line that utilizes superior moisture control fabric. The VATA Brasil OneFit fabric is an amazing innovation in sporting wear apparel, offering the advantages of being lightweight, highly elastic, and having four times the filaments than regular fabric.

The company’s newest product, The BUDDY Tablet Caddy™, is a personal, compact and portable tablet caddy with three individual compartments and a digital timer to remind users when it’s time to take vitamins or prescriptions. The pharmacist approved tablet caddy ensures the maximum effectiveness of all medications and supplements.

Founder and CEO Danny Alex leads the company with nearly three decades of experience in the health, fitness and athletic lifestyle. Since a young age, regular exercising and maintaining a healthy lifestyle has been a key part of Danny’s life. Today, it is his passion to help others get excited about themselves through fitness and healthy living. Disclaimer

Muscle Flex Inc. Blog

Muscle Flex Inc. News:

Muscle Flex Inc. Calls the Initial Test of the Beagle StepFit "Successful"

Muscle Flex Inc. Upgraded to 'Current Information' on Pink Sheets

Muscle Flex Ready to Go for a Monday, December 7, 2009 National Release of the Beagle StepFit Commercial

Royal Quantum Group, Inc. (RYQG)

The QualityStocks Daily Newsletter would like to spotlight Royal Quantum Group, Inc. (RYQG) Today, Royal Quantum Group, Inc. closed trading at $0.1450, which was up 3.57 percent. Their volume today was 139,840 shares.

Royal Quantum Group, Inc. (RYQG) announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs, and Message Boards.

Royal Quantum Group, Inc. (RYQG) is focused on acquiring, exploring and developing resource properties located within favorable geo-political climates. Led by a highly skilled, experienced board and management team, the company is strategically positioned to benefit from rising commodity prices.

The company currently has two oil and gas prospects located on the Nemaha Ridge in North Central Oklahoma. The Nemaha Ridge is characterized by a number of pay zones at relatively shallow depths. In the mapped area, eight different horizons have been found to be productive of oil and gas.

Royal Quantum Group, Inc. (RYQG) Bond Prospect is considered a low risk investment with at least ten different formations productive in the prospect area. The location has been interpreted to have the potential to hold more than 80,000 barrels of recoverable oil, plus gas valued at 20 to 30 percent of oil reserves.

The company is committed to creating value for its shareholders by building a portfolio of resource properties with the objective of advancing them to profitability. Royal Quantum Group’s management has a history of successfully managing early stage mineral exploration companies, and has great potential to lead the company to greater success. Disclaimer

Royal Quantum Group, Inc. Blog

Royal Quantum Group, Inc. News:

Royal Quantum Group, Inc. (RYQG) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

(OTCBB: RYQG) Begins Oil Extraction on Oklahoma Well

/ CORRECTION - Royal Quantum Announces Successful Completion of Bond #1-18

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.0130, which was up 4.00 percent. Their volume today was 154,000 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. (KBLB) is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

News for Kraig Biocraft Laboratories Inc.

The New Age of Partnerships

Kraig Biocraft Laboratories, Inc. Greatly Exceeds Its Performance Goals

SectorWatch.biz: Paving the Way for Spider Silk

FormCap Corp. (FRMC)

The QualityStocks Daily Newsletter would like to spotlight FormCap Corp. (FRMC) Today, FormCap Corp. closed trading at $0.40, which was down 9.09 percent. Their volume today was 223,700 shares.

FormCap Corp. (FRMC) is an emerging oil & gas exploration and development company. With a primary focus on the discovery and development of oil in the Continental United States, the company has assembled 4,800 acres of oil and gas mineral leases, together called the Weber City Prospect, located in Curry County, New Mexico.

The Weber City Prospect has been defined by detailed geological information including well log data, seismic, Landsat and independent third party geological interpretation. After thorough review of the collected data, FormCap believes there is potential to drill up to 100 wells that could produce over 300 million barrels of oil.

The initial well will be drilled to a total depth of 6,500' to test four potential productive hydrocarbon zones; the San Andres, Clearfork, Wolfcamp and, the primary objective, the Cisco Formation. The company has also outlined multiple secondary objectives in the primary producing zones of the Permain Basin of New Mexico and Texas.

The Permian Basin is very prolific and well known for its oil production. Owning their leases 100%, FormCap is fully in charge of its exploration and drill plan. The four well established formations should provide FormCap with a relatively low risk opportunity as the company’s experienced management team dedicates all efforts towards profitability. Disclaimer

FormCap Corp. Blog

FormCap Corp. News:

Formcap Hires Senior Geologist Thomas Markham

FormCap Corporation - Corporate Update

FORMCAP Acquires 4,800 Acres in New Mexico

Muscle Flex Inc. (MFLI) Proclaims Successful Initial Test of the Beagle StepFit

Muscle Flex Inc. this morning announced the preliminary results from its initial week of national test advertising for the Beagle StepFit. The company told investors that it is very pleased with a number of metrics associated with the first week of advertising that aired on 7 national cable stations. These elements include the following:

1. All of the elements associated with Muscle Flex’s entire direct
response mechanism from order capture, data transmittal to Moulton,
data management, reporting, merchant accounts etc. performed
flawlessly. Muscle Flex is confident in its direct response mechanism
performing at optimum efficiency on high volumes consistent with
marketing multiple products with high advertising budgets.
2. Sales for the Beagle StepFit accelerated and maintained consistency
throughout the week.
3. Up-sell targets were surpassed.
4. Strategic information garnered will enhance and improve overall sales conversions and maximize product up-sells.

Muscle Flex up-sold its BUDDY Tablet Caddy on the Beagle StepFit offer. Muscle Flex believes a 4 week time frame is needed to achieve a profitable ad campaign for its products. Given initial results, the start of the “fitness season” in January and the start of the “outdoor” season in early February, the Beagle StepFit may be a highly profitable product for Muscle Flex. Also, The Beagle StepFit commercials will be aired simultaneously with the BUDDY Tablet Caddy in January, producing added repetition as well as increased up-sell sales numbers for both products.

The company believes this successful initial test gives the green light for not only the Beagle StepFit and BUDDY Tablet Caddy, but for additional products in its pipeline. A stable, accurate and dependable direct response delivery chain is the basis for any successful product launch. Muscle Flex promised to provide investors with additional information regarding the simultaneous January launch of the Beagle StepFit and the BUDDY Tablet Caddy in the coming days.

Revolutions Medical Corp. (RMCP) Reaches Primary Milestone

One company that has quickly started to catch the attention of investors in the medical field is Revolutions Medical Corporation (RevMed). RevMed creates software solutions and proprietary tools that are compatible with standard MRIs and standard PACS.
Today, RevMed took a major step towards enhancing the future of their company with the announcement that it has initiated the mass manufacturing process for its RevVac safety syringe, which has already been approved by the FDA.

This is a primary milestone for a company which already produces RevColor, Rev Display and Rev3D MRI Technology and will allow RevMed to satisfy its previously announced commitment to begin production in the fourth quarter of this year. RevMed has also announced that it is on pace to meet its Q2 2010 sales launch goal and $14.8 million in 2010 revenue projection

When asked about the future of RevMed and the effects of reaching this milestone, the company CTO Richard Rheriault was quoted as saying, “After years in developing what we believe is the world’s best safety syringe, we are extremely pleased to announce that the plan is now reality — we have launched the mass manufacturing process for the RevVac safety syringe. This constitutes the next step toward full scale high volume production and commercialization.”

He continued, “With this first phase we will 1) provide market-ready samples and 2) complete the steps necessary to ensure ultimate delivery of a high quality, high volume manufacturing solution. We have been working closely with the team at Goddard Technologies (www.goddardtech.com) — the group responsible for the recent crucial product refinements — towards this, our primary pre-sales milestone. We remain precisely on pace with our stated goals, and we can now demonstrate tangible progress toward bringing the much-anticipated RevVac to market in Q2 ‘10.”

With numerous amounts of production in their pipeline and milestones being reached well ahead of schedule, RevMed seems ready to become a major player in the medical field.

Quadra Projects Inc. (QPRJ) Announces Subsidiary to Establish an Assembly Plant in China

One company that has started to gain national recognition is Quadra Projects Inc. Located in Las Vegas, Nevada, Quadra has the mission of becoming a leader in the green energy field with their main focus on environmentally friendly opportunities which focus on leading waste to energy technology.

Today, Quadra took a major step towards enhancing their future with the announcement that its wholly owned subsidiary Quadra Energy Systems signed a Memorandum of Understanding (MOU) to enter into a Joint Venture agreement with Canda Green Industry Inc.
Canda Green has grown into a recognized name in China as a prominent real estate development company and has been appointed to develop a large high technology park in the Dalian-Jinzhou District of Liaoning Province to cater to the world’s ecological and environmental industries.

The Joint Venture proposes to establish a plant in China for the assembly of QES2000 Systems which will be utilized to process primarily Municipal waste and Used Tires in the scientific park and elsewhere in China.

The Liaoning Coastal Economic Zone follows the earlier economic zones of the Pearl River and Yangzte River, which has the potential to make the city of Dalian the focus of the world with numerous incentives including guaranteed sources of used rubber and municipal waste.

Management of the company is of the opinion that the QES2000 System is the most advanced prolysis and gasification in the world and will far exceed the challenges of the 21st Century. It is very affordable – and provides a revenue stream from the by-products – making the return on the investment much greater than other competitive systems.

Currently, Quadra Projects is trading in the $0.15 range. With the success of its subsidiary, a strong plan in place and the entrance into a fruitful market, Quadra Projects may be a hidden gem.

Electric Car Company, Inc. (ELCR) Finalizes Agreement with Electric Vehicle Conversions, LLC

Friday, Electric Car Company, Inc., a vehicle conversion company specializing in electric conversions, announced that it has finalized an agreement with Florida-based Electric Vehicle Performance Conversions, LLC. (EVPC).

In October 2009, ECC announced that it had signed a Letter Of Intent with EVPC to provide complete turnkey, electric power conversion consulting and technical services to ECC’s line of Livery and Fleet vehicles. The conversion is slated to include “Specialty Buses” for commuter, transit, limousine and sightseeing transportation industries.
The companies will work closely to create and develop matched Electric Vehicle and Hybrid systems, including electric drive systems for livery vehicle trucks weighing over one ton. The development will also extend to buses and limousine livery vehicles.

As per the agreement, EVPC will assist in establishing the Franchising Division with duties that include the new EV and Hybrid systems design consulting. While the agreement lasts, ECC and EVPC will jointly own and develop a proprietary Franchise Division. EVPC will contribute knowledge and sales assistance to ECC’s current and potential clients in order to increase the number of conversion franchises throughout the world.

Mr. Gary Spaniak, CEO of Electric Car Company, Inc. commented, “We are very happy to conclude this Agreement. EVPC has a proven successful track record in Electric Vehicle technologies and will be a great partner to help expedite our Electric and Hybrid products for our clients.”

 


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336